<SUBMISSION>
<ACCESSION-NUMBER>0000914062-08-000015
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>4
<PERIOD>20080110
<ITEMS>2.02
<ITEMS>9.01
<FILING-DATE>20080115
<DATE-OF-FILING-DATE-CHANGE>20080115
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CRYOLIFE INC
<CIK>0000784199
<ASSIGNED-SIC>3841
<IRS-NUMBER>592417093
<STATE-OF-INCORPORATION>FL
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-13165
<FILM-NUMBER>08531070
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1655 ROBERTS BOULEVARD N W
<STREET2>STE 142
<CITY>KENNESAW
<STATE>GA
<ZIP>30144
<PHONE>7704193355
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1655 ROBERTS BOULEVARD N W
<STREET2>STE 142
<CITY>KENNESAW
<STATE>GA
<ZIP>30144
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cryolife8k11008.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>

  <head>
    <title>cryolife8k11008.htm</title>
<!-- Licensed to: AGG-->
<!-- Document Created using EDGARizer 4.0.3.0 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff">
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td valign="top" width="80%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">UNITED
      STATES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SECURITIES
      AND EXCHANGE COMMISSION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman; FONT-VARIANT: small-caps">washington,
      d.c. 20549</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div align="center">
      <table cellpadding="0" cellspacing="0" width="21%">

          <tr>
            <td valign="top" width="21%" style="BORDER-TOP: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt">
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">FORM
                8-K</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt">
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CURRENT
      REPORT</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PURSUANT
      TO SECTION 13 OR 15(d) OF THE</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES
      EXCHANGE ACT OF 1934</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date
      of Report (Date of earliest event reported):&#160;&#160;January 10,
      2008</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_______________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">CRYOLIFE,
      INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Exact
      name of registrant as specified in its charter)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_________________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td valign="top" width="27%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Florida</font></div>
            </td>
            <td valign="top" width="27%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1-13165</font></div>
            </td>
            <td valign="top" width="27%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">59-2417093</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="27%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(State
                or Other Jurisdiction</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">of
                Incorporation)</font></div>
            </td>
            <td valign="top" width="27%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Commission
                File Number)</font></div>
            </td>
            <td valign="top" width="27%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(IRS
                Employer</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Identification
                No.)</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1655
      Roberts Boulevard, N.W., Kennesaw, Georgia&#160;&#160;30144</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address
      of principal executive office) (zip code)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registrant's
      telephone number, including area code: (770) 419-3355</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_____________________________________________________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Former
      name or former address, if changed since last report)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_________________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Check
      the appropriate box below if the
      Form 8-K filing is intended to simultaneously satisfy the filing obligation
      of
      the registrant under any of the following provisions (see General Instruction
      A.2. below):</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top">
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Written
                communications pursuant to Rule 425 under the Securities Act (17
                CFR
                230.425) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top">
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Soliciting
                material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
                240.14a-12) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top">
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pre-commencement
                communications pursuant to Rule 14d-2(b) under the Exchange Act (17
                CFR
                240.14d-2(b)) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top">
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pre-commencement
                communications pursuant to Rule 13e-4(c) under the Exchange Act (17
                CFR
                240.13e-4(c)) </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td valign="top" width="80%" style="BORDER-TOP: black 2.25pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>

      </table>
    </div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
      2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
      Information</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item
      2.02&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Results of Operations and
      Financial Condition.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>On
      January 10, 2008, CryoLife, Inc.
      (&#8220;CryoLife&#8221; or the &#8220;Company&#8221;) issued a press release announcing its preliminary
      revenue results for fiscal 2007 and the fourth quarter thereof. CryoLife hereby
      incorporates by reference herein the information set forth in its Press Release
      dated January 10, 2008, a copy of which is attached hereto as Exhibit 99.1.
      Except as otherwise provided in the press release, the press release speaks
      only
      as of the date of such press release, and it shall not create any implication
      that the affairs of CryoLife have continued unchanged since such
      date.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; COLOR: #000000">All
      statements relating to the Company's
      fourth quarter and full year 2007 revenues contained in the attached press
      release are preliminary and unaudited and may change based on the completion
      by
      the Company's management and independent auditors of customary year-end closing
      procedures.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The
      press release includes tissue
      preservation and product revenues and combined cardiac and vascular tissue
      preservation services revenues.&#160;&#160;The Company&#8217;s GAAP revenues <font style="DISPLAY: inline; COLOR: #333333">are composed of tissue preservation
      services and product revenues plus other revenues, which include grant and
      license revenues. Total other revenues for 2007 are not finalized, but are
      not
      expected to exceed one percent of total revenues.&#160;&#160;Combined cardiac
      and vascular preservation services revenues have been adjusted from the
      comparable segment revenue numbers to exclude revenues related to orthopedic
      tissue preservation services.</font><font style="DISPLAY: inline; COLOR: #333333">&#160;</font>Tissue processing
      segment
      revenues have been adjusted to exclude revenues from orthopedic tissue
      processing because the Company discontinued procuring and processing such tissue
      as of January 1, 2007 and is currently only distributing those tissues that
      were
      processed prior to that time.&#160;&#160;Because the Company&#8217;s revenues from
      these tissues will be reduced to zero in the near future, the Company believes
      that the non-GAAP revenue numbers presented provide investors with a more
      accurate measure of the relative revenue performance of the Company&#8217;s continuing
      tissue preservation business.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>CryoLife
      believes that providing
      adjusted non-GAAP revenues provides investors with greater transparency to
      the
      information used by CryoLife&#8217;s management in its financial and operational
      decision-making and allows investors to see CryoLife&#8217;s results through the eyes
      of management. CryoLife considers these non-GAAP financial measures to be useful
      metrics for management and investors, allowing CryoLife&#8217;s management and
      investors to compare CryoLife&#8217;s recurring core business operating results over
      multiple periods.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accordingly,
      CryoLife<font style="DISPLAY: inline; COLOR: #000000"> believes that these
      non-GAAP measures, when read in conjunction with the Company&#8217;s GAAP financials,
      provide useful information to investors by offering:</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">

          <tr valign="top">
            <td align="right" style="WIDTH: 36pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000;" face="Symbol, serif"><font style="DISPLAY: inline; COLOR: #000000">&#183;</font>&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">the
                ability to make more
                meaningful period-to-period comparisons of the Company&#8217;s on-going
                operating results;</font></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">

          <tr valign="top">
            <td align="right" style="WIDTH: 36pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000;" face="Symbol, serif"><font style="DISPLAY: inline; COLOR: #000000">&#183;</font>&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">the
                ability to better identify
                trends in the Company&#8217;s underlying business and perform related trend
                analyses; and</font></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">

          <tr valign="top">
            <td align="right" style="WIDTH: 36pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000;" face="Symbol, serif"><font style="DISPLAY: inline; COLOR: #000000">&#183;</font>&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">a
                better understanding of how
                management plans and measures the Company&#8217;s underlying
                business.</font></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The
      information provided pursuant to
      this Item 2.02 is to be considered &#8220;furnished&#8221; pursuant to Item 2.02 of Form 8-K
      and shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the
      Securities Exchange Act of 1934, as amended, or otherwise subject to the
      liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act
      of
      1933, as amended, nor shall it be deemed incorporated by reference into any
      of
      CryoLife&#8217;s reports or filings with the Securities and Exchange Commission
      (&#8220;SEC&#8221;), whether made before or after the date hereof, except as expressly set
      forth by specific reference in such report or filing.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Except
      for the historical information
      contained in this report, the statements made by CryoLife are forward-looking
      statements that involve risks and uncertainties. All such statements are subject
      to the safe harbor created by the Private Securities Litigation Reform Act
      of
      1995. CryoLife&#8217;s future financial performance could differ significantly from
      the expectations of management and from results expressed or implied in the
      press release.&#160; Please refer to the last paragraph of the press release for
      further discussion about forward-looking statements. For further information
      on
      risk factors, please refer to &#8220;Risk Factors&#8221; contained in CryoLife&#8217;s Form 10-K
      for the year ended December 31, 2006, as filed with the SEC, and any subsequent
      SEC filings. CryoLife disclaims any obligation or duty to update or modify
      these
      forward-looking statements.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">Section
      9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; COLOR: #000000">Financial Statements
      and
      Exhibits</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">Item
      9.01(c)</font>&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; COLOR: #000000">Exhibits.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">(a)&#160;&#160;
Financial
      Statements.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; COLOR: #000000">Not
      applicable.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">(b)&#160;&#160;
Pro
      Forma Financial
      Information.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; COLOR: #000000">Not
      applicable.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">(c)&#160;&#160;
Shell
      Company
      Transactions.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; COLOR: #000000">Not
      applicable.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">(d)&#160;&#160;
      Exhibits.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td valign="top" width="5%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Exhibit
                Number</font></font></div>
            </td>
            <td valign="top" width="80%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Description</font></font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="80%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="15%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99.1</font></div>
            </td>
            <td valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Press
                release dated January 10, 2008</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div><br>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc.
      has
      duly caused this report to be signed on its behalf by the undersigned hereunto
      duly authorized.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td align="left" valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CRYOLIFE,
                INC.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date:&#160;&#160;January
                15, 2008</font></div>
            </td>
            <td valign="top" width="40%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                <font style="DISPLAY: inline">/s/ D. Ashley Lee</font></font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:&#160;&#160;&#160;&#160;
                D. Ashley Lee</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td align="left" valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:&#160;&#160;&#160;&#160;&#160;&#160;
                Executive Vice President, Chief Operating Officer and Chief Financial
                Officer</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
  </body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cryolife8k11008ex99.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>

  <head>
    <title>cryolife8k11008ex99.htm</title>
<!-- Licensed to: AGG-->
<!-- Document Created using EDGARizer 4.0.3.0 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff"><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exhibit
      99.1</font>&#160;</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><img src="cryolife4q1.jpg" alt=""></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">FOR
      IMMEDIATE RELEASE</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Media
      Contacts:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="61%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">D.
                Ashley Lee</font></div>
            </td>
            <td align="left" valign="top" width="19%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mike
                Greenwell</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="61%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive
                Vice President, Chief Operating Officer and</font></div>
            </td>
            <td align="left" valign="top" width="19%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fleishman
                Hillard</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="61%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief
                Financial Officer</font></div>
            </td>
            <td align="left" valign="top" width="19%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phone:
                404-739-0155</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="61%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phone:
                770-419-3355</font></div>
            </td>
            <td valign="top" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CryoLife
      Announces Record Preservation Services</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">and
      Product Revenues for 2007</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Preliminary
      full year and fourth quarter 2007 preservation services and product revenues
      </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">increased
      16% and 17%, respectively, to approximately $93.7 million for the year and
      $24.6
</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">million
      for the fourth quarter</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">ATLANTA&#8230;(</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">January
      10, 2008</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; COLOR: #000000">)&#8230;CryoLife,
      Inc.
      (NYSE: CRY)</font><font style="DISPLAY: inline; COLOR: #000000">, a
      biomaterials, medical device and tissue processing company, </font>announced
      today that preservation services and product revenues for 2007 were
      approximately $93.7 million compared to $81.1 million in 2006, an increase
      of 16
      percent.&#160;&#160;Preservation services and product revenues for the fourth
      quarter of 2007 were approximately $24.6 million compared to $21.0 million
      in
      the fourth quarter of 2006, an increase of 17 percent.&#160;&#160;The Company&#8217;s
      GAAP revenues are composed of preservation services and product revenues plus
      other revenues, which include grant and license revenues.&#160;&#160;Total other
      revenues for 2007 are not finalized, but are not expected to exceed one percent
      of total revenues.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>BioGlue<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">&#174;</font>
      revenues
      were approximately $43.9 million for the full year of 2007 compared to $40.0
      million in 2006, an increase of 10 percent.&#160;&#160;BioGlue revenues were
      approximately $11.5 million in the fourth quarter of 2007, compared to $10.5
      million in the fourth quarter of 2006, an increase of 10 percent.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Total
      tissue preservation services
      revenues were approximately $49.0 million for the full year of 2007 compared
      to
      $40.1 million in 2006, an increase of 22 percent.&#160;&#160;Tissue preservation
      services revenues were approximately $13.0 million in the fourth quarter of
      2007, compared to $10.2 million in the fourth quarter of 2006, an increase
      of 27
      percent.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-
      more
      -</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><img src="cryolife4q2.jpg" alt=""></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Combined
      cardiac and vascular tissue
      preservation revenues increased 36 percent for the full year of 2007 to $44.8
      million compared to $32.9 million in 2006, on a 25 percent increase in unit
      shipments.&#160;&#160;Combined cardiac and vascular tissue preservation revenues
      increased 49 percent in the fourth quarter of 2007 to $12.4 million, compared
      to
      $8.3 million in the fourth quarter of 2006, on a 41 percent increase in unit
      shipments.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Orthopaedic
      tissue preservation
      revenues decreased 41 percent for the full year of 2007 to $4.2 million,
      compared to $7.1 million in 2006, and decreased 71 percent for the fourth
      quarter of 2007 to $552,000, compared to $1.9 million in the fourth quarter
      of
      2006 because the Company stopped procuring and processing such tissue in January
      2007 pursuant to its Exchange and Service Agreement with Regeneration
      Technologies, Inc.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;The
      strategic initiative that we
      announced in late 2006 and implemented throughout 2007 has resulted in record
      setting tissue preservation and product revenues for fiscal year 2007,&#8221; noted
      Steven G. Anderson, CryoLife president and chief executive officer.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #191919; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; COLOR: #191919">All
      statements relating to the Company&#8217;s
      fourth quarter and full year 2007 revenues contained in this release are
      preliminary and unaudited and may change based on the completion by the
      Company&#8217;s management and independent auditors of customary year-end closing
      procedures.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">About
      CryoLife, Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #000000">Founded
      in 1984, CryoLife, Inc. is a
      leader in the processing and distribution of implantable living human tissues
      for use in cardiac and vascular surgeries throughout the </font><font style="DISPLAY: inline; COLOR: #000000">United States</font><font style="DISPLAY: inline; COLOR: #000000">and
</font><font style="DISPLAY: inline; COLOR: #000000">Canada</font><font style="DISPLAY: inline; COLOR: #000000">.&#160;&#160;The
      Company's
      BioGlue</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super; COLOR: #000000">&#174;</font><font style="DISPLAY: inline; COLOR: #000000">Surgical
      Adhesive is FDA approved as an
      adjunct to sutures and staples for use in adult patients in open surgical repair
      of large vessels.&#160;&#160;BioGlue is also CE marked in the European Community
      and approved in </font><font style="DISPLAY: inline; COLOR: #000000">Canada</font><font style="DISPLAY: inline; COLOR: #000000">and
</font><font style="DISPLAY: inline; COLOR: #000000">Australia</font><font style="DISPLAY: inline; COLOR: #000000">for
      use in soft tissue
      repair.&#160;&#160;The Company also distributes the CryoLife-O'Brien</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super; COLOR: #000000">&#174;</font><font style="DISPLAY: inline; COLOR: #000000">stentless
      porcine heart valve which is
      CE marked for distribution within the European Community.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #333333; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #333333">Statements
      made in this press release
      that look forward in time or that express management's beliefs, expectations
      or
      hopes are forward-looking statements within the meaning of the Private
      Securities Litigation Reform Act of 1995. These statements include those
      regarding anticipated revenues for the fourth quarter and full year of
      2007.&#160;&#160;These future events may not occur as and when expected, if at
      all, and, together with the Company's business, are subject to various risks
      and
      uncertainties. These risks and uncertainties include that completion by the
      Company's management and independent auditors of customary quarter-end closing
      procedures could result in an adjustment to the Company's fourth quarter and
      full year 2007 revenue numbers, and other risk factors detailed in CryoLife's
      Securities and Exchange Commission filings, including CryoLife's Form 10-K
      filing for the year ended December 31, 2006, its most recent Form 10-Q, and
      the
      Company's other SEC filings. The Company does not undertake to update its
      forward- looking statements.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-
      more
      -</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CRYOLIFE,
      INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financial
      Highlights</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In
      thousands)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="6" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three
                  Months Ended</font></div>
              </td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="6" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Twelve
                  Months Ended</font></div>
              </td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December
                  31,</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December
                  31,</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2007</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2006</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2007</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2006</font></font></div>
              </td>
              <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="6" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Unaudited)</font></div>
              </td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="6" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Unaudited)</font></div>
              </td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenues
                  from:</font></div>
              </td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="#cceeff">
              <td align="left" valign="bottom" width="52%" style="PADDING-LEFT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cardiovascular</font></div>
              </td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,511</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,438</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,098</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,988</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="52%" style="PADDING-LEFT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vascular</font></div>
              </td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,920</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,890</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,702</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,956</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="#cceeff">
              <td align="left" valign="bottom" width="52%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Orthopaedic</font></div>
              </td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">552</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,911</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,202</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">7,134</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;Total
                  preservation services</font></div>
              </td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">12,983</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">10,239</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">49,002</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">40,078</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="#cceeff">
              <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="52%" style="PADDING-LEFT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">BioGlue</font></div>
              </td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,511</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,491</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43,884</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40,025</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="#cceeff">
              <td align="left" valign="bottom" width="52%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other
                  implantable medical devices</font></div>
              </td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">105</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">238</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">828</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,012</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="52%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
                  products</font></div>
              </td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">11,616</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">10,729</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">44,712</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">41,037</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="#cceeff">
              <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="52%" style="PADDING-LEFT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
                  preservation services and product</font></div>
              </td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="#cceeff">
              <td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;revenues</font></div>
              </td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">24,599</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">20,968</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">93,714</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
              <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">81,115</font></font></td>
              <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
      revenues for the full year and fourth quarter of 2006 were $196,000 and
      $122,000, respectively.&#160;&#160;Total revenues for the full year and fourth
      quarter of 2006 were $81.3 million and $21.1 million, respectively.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
      additional information about the company, visit CryoLife&#8217;s Web
      site:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #0000ff; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">http://www.cryolife.com</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">END</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div><br></body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>cryolife4q1.jpg
<TEXT>
begin 644 cryolife4q1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#__@`<4V]F='=A<F4Z($UI8W)O<V]F="!/
M9F9I8V7_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-#AT5%A$8(Q\E)"(?(B$F
M*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_P``+"`!J`10!`1$`_\0`
M'``!``(#`0$!``````````````4&`P0'`@$(_\0`1A```0,#`P,"!`0"!`D-
M`````0(#!``%$082(0<3,4%1%")A<14R@9$CH0@60K$7)#,T<H*2LL$E-C=%
M4E1B=**CPM'2_]T`!``H_]H`"`$!```_`.RTJB:OZJV[2.H&[0]`>DJVI6\X
MA8`;"O&!ZG'/I5H&I+*;G'M@N3'QLE&]IC=\Y&,^/3CWK3E:WT^Q;+E.9N#4
MH6P*[[3*LK!!QC'WXSXK0T)U!AZY1+#,-R(_%*2MM:@H%*LX(.!['BK=2L$R
M;%MT1R7-D-QV&QE;CJ@E*1]S5#N'6W24-XML?&3<'&]ED!)^VXBIG2_4:P:N
MF_!6U<@20T75-NM;=J00#SX]15JI2E*5\4=J2K!.!G`\FJG9>I>G+_=V[5;U
MRG)3A/RF.H!.!DDGT'%6VHU.HK*N\FSIN<95P'F,'!O\9QCWQZ5ZN]^M-A82
M]=;@Q#0LX3W5X*C]!Y-?+)?K=J*"9UK?[\<.*;[FTIR1YQFI&M2=<X5L2A4R
M0AKN'"`<DJ/K@#DUFC2F)L=,B,\AUI7A:#D5H7W4EITTPT_=Y?PK3R]B%E"E
M#=C..`<5ELU\MNH(/QMJE"3'WE'<"2!D>1R![UOTI2E*4I7#=>79RY:@<NLO
M0:G(5H=#,B1(*TEP9P`2D@8R>//GZUBZ3*LK.N7V;@PE^9('>MLMTYXY.`/&
MXC]MI%0NJ9VFH_4*5(MMN;-MA@I>82LA$MSD$#V!)]/1)-?_T-GI5<9-JN*;
M.[I!RWBYH^)1+;W$%&"1N*R>.<#!]?'-=<KX2`,DX`K\YZUU'=.HNLDVBUE3
MD1+Q9AL)5A*R/+A^_)SZ"K]9^A=ACPT_BTF3,DD#>6E]M"3[`8S^]2^F>F=O
MT=J9R\6Z:\J.J,MI3#PW%.2DY"AZ?+XQ4Q&UYI267`S?H9[2"M>7-NU(\GFO
M#/4#2S\9^4W=VS&CN);<?*%!`4H$@9Q]#4A9]1V>_ATVFX,S`SCN=HYVYSC/
M[&LUVO-NL4,2[I+;BL%01W'/&3X'\JUH&JK#=(TB5"NL=Z/&`+SH5A#>?<G@
M5%_X3=%_$=C\?C[LXSA6W_:QBK+%E1YL=$F(^V^RX,H<;4%)4/H17`.E'\+J
MPIL#C$A/VQG_`.J_0E<<BZ)L\7J8;R-7V\M-S%R?A^\.^%@E2D'GP#G)]AXJ
MJ:_EQ]2]4RPNZM&WJ<981)2L*;:;(&X@^."2:[5H:S6?3]@7$LUS$^'WU++Q
M<2O:K`R,IX],_K65[7>E&)1C.:@@)=!P1W@0#]_%1^K+$]J%461#/Q,1U*4N
MJCN([B4A6X*;*OE()P#SZ#VJ3TE:9-HM'9EI0AU:@HH2K=C"$IR3ZJ.W<?J?
M7S53ZZ(W:&85@?+.1_NJK9Z*9_P>M?\`F7?[Q5PGWRT6M81/N<2*L^$O/)0?
MV)K:CRH\QD/17VWVE>%M+"DG]17M:T-H*W%)0A(R5*.`!46C56G7'BRB^VY3
MB3@I$I&?[ZE00H`@@@\@BOM*5S#6W4JU3[1=+)89TL79OAIQA"D[BE0*@E0Y
M\!7[5$P^KEF5I)FRWRUW68M44,2G"E)[AQ@G)5G]:V-!=+H%PM$*\7.5(>:4
M2["9;46E-H).-RASGUP",'/G-:&LM`6;1C]NNKBGG[$W*_CQ$@*>6LY(^8X!
M3\H'/@9\YK[JSJ]'U!8/PW3C%TASW'4;%(PD[1Z#8HGGVJ]Z9Z@V"[2XUB1/
M4Y<DLI2O>@[7%I3\P"CY/!^^*G=2N.,Z6NSK)(<1">4@CSG8<5Q+H4TPO6LA
M;@!=;A++6?0E20?Y&OT!7__1[&O\BOL:_+&F=+R=8:K5:H[J&-Q6XXXL9V)!
MYX]3R*[C8.EUNL=ANUG5-=F,71"4K[B`-A`.",?4Y_2N:],[I)T7U$>L-P.Q
MN4X8CH/@.`_(K]3Q]E5*=:M3.7.[QM)V\EP,K2I]*.=[JN$I_0']U?2JI-B7
M"XW>'H&U+_A17>TM(.$.R/+KBO<`@@>P2*Z(GH)9?PWMJNLSXW;_`)8!.S=_
MH8SC]:JNA;O=.G_4$Z9N+I,5Y\,.M@Y2%*_(XGVSD?H:U^EJ<]7!GC:9)Q^B
MJ_0]?F^7;E7#K1/MS;O95*GOMAS&=NX*YQ^M1,[2'P6OTZ4^.WYDML?$=O&-
MP'.W/IGWJ9U89VB(:]!P;GWVW7?B)3J$]LJW@!+9YX&!D\\Y%3L?H[8Q:$JF
MZMCM7!2,X2XWVDJQXY.3]ZQ=(M1S;'JQW2<R0'8KRUH;"5[D(=3GE)]E`'QY
MXKNM<XZY_P#,1K@_Y\W_`+JZJ%KU/<]+]%(TBUK;;>DW!U@N*3E2`03E/IGC
MUK5TETGGZSM7X]<;R8XE*46R4%UQS!P5*)(QR#[U@L$B[],>I*+*Y(#S#KS;
M3Z$$['4+QM4!Z$9!_<5M:TOMYZB:X.F+0X1#:>4TVV%$)64_F<7[@8./I]34
MI)Z`NH@;HU]2Y,`SL<8VMJ/MG)(_:NRL([4=ML^4("?V%9*4KD>L^GEOTK;[
MAJFQ.S47!*@6&T*R&5+4`HIP,^"<<\5IP>F=QG:8C7F=K2;$0[&$AY#J%$-#
M&3R5^G/I4[H#J18QI^);KG,,-R/EAI^4<)D!/]K/IP1D'U/DUH:VUG:-72;=
MIJW7-R+'E2<KNB0>V%`$!`&03DD9/`Y'FH;5&@[[H:T-WF!J67*>:?2A+;31
M21G//YC[>U7;2?3"S6>[1]1I7(5)4V'$,+(V,K4GYL<9/DXSXJ].MH>:6TXG
M<A:2E0/J#YK\U2&[GTKZA=Q#94F.LEK=PF0PKTS]N/H17;[)U)TK?(R76[JQ
M%=*<J8E+#:T>_G@_I6U"UI8+M>%VBVST2Y*6%/*+/S(2D$#\WC//@5QWHN0K
MJ1((Y!C/$?[2:_0-<2ZXZ=7#N</4\-)0'L-/K1QM<3RA7Z@8_P!45']']/OZ
MCU<]J*XJ6^B$KN%QPY+CZO&3ZXY/[5__TJY\6=`]9WY=P0OL"4XM2L9):=SA
M0]\!7\C7=4ZEL2K>9Z;O",4)W%WOIP!^_P#*N$/RAKWK,U)MJ%EA<IHI5C![
M;0&5_3(3G]17CIK<(D/JF)4N0W&949'SNK"4C(5C)-=W<U7IUIM3B[[;@E(R
M<2D'^XUQ2+@_T@B0<@W19!_0TO:2?Z0*``2?Q*/_`'(K7ZSVUV)U`<E/`AB:
MTVM"\>P"5#[C'\Q4S;NB$2[06IT#5;;\9U.Y*T1L_P#RX^U;^F^DD:!>6+M"
MU8S(_#)*5.A#`P"G!*2=W'!_G748E_LT]Y+,.[0I#J_RH:D)4H_8`YJB]=7-
MNB8R.?GG(\>.$JKG4[_H/MG/_6[G^ZJNP=*0!TVM&/5"S_[BJY7U.!/6%L`<
ME47'U_+7S14V-HOJU,8O"@R@K>C%U?A!4H%*B?8X'/UKOK\V+&B&6_)::CA.
MXNK6`G'OFL4Z\6RV=KX^X1HO>.&^\Z$;_MFML$$`@Y!\$5]I2N*:TAZT%R?T
M[+U/`=@W9[N(2Z\AM:$[LA.T_,!XX&0<5I])K+;+YJIZ;*<9+5L1VXD)PC>O
MS\Y3ZXY)^I^E06I=+QHFNI>G+7+CK9D$O1U%["8RL%12H^!C!'/I@UT?IPYK
M&\SV[I=+]$>MT5HQS&8<2YW#C@JV\`\`Y)S^]=-I4-J;2EIU;;_@[K'W[>6W
M4'#C1]TG_AXKED[H#+#Q-OOC"VB>!(:*5`?<9S5BT+THD:0O)N;MV:D+5'6R
M6T,D`%6,'.>?%9]%]*U:/U'^+IO`E!32VUMF/L_-@Y!W'U%=#KB'6_4BY]VB
MZ7A**TL$./I3_:=5^5/Z`_\`JKI^A]-HTKI6);,#O!/<D*']IQ7*OV\?85AU
MEH2TZTB(1,"F)37^2E-`;TCV/N/I7-O\`%P^(Q^/1NSG\W95NQ]LX_G71M'Z
M!M6C(C@@DO374X<EO#YC]`!X3GT_G5">Z!/.O+<_K&CYU%7^:>_^M7@?T?WP
M01J)O(/_`'4__JO_TYN%TIFQ]<-ZH>O;+CJ9/?4RF,0#Z8!W>U>IO2V=,Z@'
M5?XRR@B4A]#/PY/"<823N]AYJUZMTC;=8VKX&X!2%(.YE]'YFE>X]Q[CUKE"
M^ANI8[JFX=[B=A1\E3B"1]4@'^^KQIW3[_3GI[=T3)3,E:$NR`6P0G\@`'/U
M'\ZK_0_2*8\)S4\ML%V1EJ*"/R(!PI7ZGC[`^]7'J#H^1K6SQ[<Q-:B);?[J
MEK;*R<`@`8(QYJMR.DLU[0L330O#`,>8J27^P>01@#&?J:NFC[`YIC3$2SNO
MHD*C;AW$)*0K*B?!/UJIZKZ7S-1ZS3J!JZLQP@M%+2FBH_)CUS6_KWIC`UFH
M36GO@KDA(3W@G<EP#P%#_C_?7/V>B.JR^EIZYP1';4"G+RU`X]D[>*MO4?IA
M<=87B)/@W!EL(9#+C;^<)`).Y.`??Q]*O]GMXM-FAVX.J>^%80UW%>5;1C-;
ME*5S;6724ZJU8F\HNWP[3H0'VR@J4-HQ\ASZ@59VM":=8U(UJ!B`EJ<T",H.
M$*)&-Q3XW8SS]:C)/2K3GX-<X<"/\-)GA7^-*)6MO)W`#/A.1C`\BOG3CI^Y
MH=F:9$],IZ6I.>VDI2E*<X\^3R:NU*4I2L4E3Z(KJHK:''P@EM"U;4J5Z`GT
M%<ITMTMOC.N!J+4KL-\!U4@I:<4HET\@X('`//Z"NMTI2E*^9&<9K[2E?"D*
M!"@"#Y!K_]3LB4I0G:E(2!Z`8K[2E*4I2E*4I2E*51-6HGRM1R68,69+<9M2
M7&TL3C'#+A6O"\9`4>/KXJ0CZF[<%IQA"ILAZ/#2TMQPH2\MW<`2/['@DX'T
M]JQ3]1WU#GP+,>$Q.8N$=AXJ<4IMQMSD%)QD$X((/BO3>MWGK^J"S;''8[<S
MX-Q:$.%25#\SGY=NP'C\V?6M2\WF[7;14NY-PF&HCZ4+BXD*[I_BI"=PVX&[
MZ'BMYW4]X8<=@+ML15Q1,98`2^KM%+J2H*SMSQM.1CTKVQJ6Z3$L0F(,5-R6
M[(;<#CQ#*>RH)400-QSN3@8]3GQ4>=5)^.1=W8JDKCVZ0E<<.9'<3(0V0%>,
M;A^;'BM^3JJX6UYZ!.MS!GX8,<,/DM+[KA;3N44@IPH<\<CQ7D:AFF8N!=(;
M33\:=%9"HTA12YW,D'P#@8_*?-8K;K>7<I"5Q[,\]%>0\6>VA>X%O.`HE(1\
M^"!@G!(J5TS?'[Y!><?:89DM+VK825[FB4@[5A200>?L?(JOZ;N5U:8#+<*"
MY<KE,ENK<4\H(V-N;25'!).2$I`'CVJ5MVJ)UVGP8T:W--AUMU<I3KQ_A%MW
MMJ2G`^;GP>*C]57.;:=:VR:W*4BWQHBUSF<G:6U.)05X_P##N"L^P-:,75LJ
M'<;Y?I;CDBWKBLNP(J"<!!=4VD_3>1NS[$5,QM927TF.+63.5)3'9&Y:&72I
M!7N"U(!P`E61CR![UKP+Q+1?)+=SCN1W5W1#6QJ05-I`C;L^.4G&<8')'M6X
M=13I%D5=7K:&;>\EM<=3<O#J@I:0-PVX3D'/!/M7MG4\Q=S+3EK2B#\>N"E\
M/Y65I!(5LV_EX(\YK!8];)O\UN.Q!<0S);<4R\DJ)3M\;\I`3D<C!/M4.;)K
M\M*:BW!#"%,*9W/R"MPG<5!WC("^`GCC"L\8Q7__U>QHR$)"O..:]4I2E*4I
M2E*BKCIJTW69\7,C+6\6NTHI>6@*1G.U020",D^?>LS]DMDEAUAV&V6W4(;4
MD9'RH_(!CQC/&/%8!I>SBWN0?A5%IUT/+47EEQ3@QA6_.[(P,'/I7M.G;6FY
M?B"8Z@_O"SAU>TK`QN*<[2K'J1FL:-*V5M;JDPOE>SN;+BRV,J"CA&=J<J`/
M`%;AM<%4M4M49!?6M"ROG)4D$)/Z!1_>L$K3UJF("7H@REU3R5H6I"TK5^8A
M22",^O-?4:?M#<<1TV]D-)CF,$;<CMDY*?U/-:;^EH+-JEQK=#CJ<DA(7\8I
M;H6$G@%1.X`>F#P>:UK!I%FWJE/S66>Y(DMR$M-N..);4@82=Z_F4KR>?I[5
M)-::L[,EV0W#"5O!84.XK9\_Y\)S@9]<`5FMEF@6=#B8+)1W2"XI;BEJ5@8&
M5*)/`X'M6&1INTR8S<=<3:AIQ;K9;<4A2%+)*B%)((R2<\UL1+5`@EDQ8J&N
MPSV6]O\`902"1^XS7V3:X,UQ;DF,AU3C"HZBKU;5C<G['`K`[I^U/-N-N0T%
M#L=$9202!VTDE*1CQ@G@CFL2M,6QR$8CHD/`NAX.N27%.I6.`H+)R"!QQ7J%
MINUP#N8865F1\2I;CJEJ4[MV;B23GY3BO#&E;1'2XVVR[V7,?P5/K+:,*"_E
M23A/S`'BMQ-JA)``8`Q(,GR?\H<Y5_,U@MVGX%J?+D0/H3R$,E]:FFP3D[4$
MX3D^U2=*4I2O_];LM*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4K__U^RTI2E*
M4I2E*4I2E*4I2E*4I2E*53VM>I8UR[IBZ0DQ0I6V++2X5(=5@*V'(&%84/4\
M_<5/66X2[@W*7*8::[,IQA';65;P@XR<@8Y]*DJIURUC/BZV<TZTQ;VVTQ/B
MC*DR%("4^,$8\Y^OBK1;W9#\!EV4EE+RTY4&5E:/T)`R,5L*SM.W&['&?&:Y
MS)ZE76+9+W-=M402;+-3'?CE]0W))P%@X]3Z>U6Z)>9$ZXP6HR([D9Z$)3[H
M4K*-WY`GCG//G_LFIFO_T.@:RU9_5=%N3L:3\?)#!D/Y[3`\E2L<_IQZ\\5-
MV]<MR*%3%1EK))2N-G8M/H>?'[G[UM4I5:UQJ67I>UQ9<-AB0Y(E(CAMXD9*
MLX((^U>]+:CEWN7=H<R&VTNV2.SWV%%33W^CGG(]1]:L55/4NJYEFU3:+-'1
M#V7)*R7I"U)[6WDDX\YJ?M$IZ;;T27G8KP<)+;D4DH6CT(S6[57L&II]XU9>
M[2Y&CHC6I:4=Y!5N<*N0,'@8P<U:*U[@^Y&MTF0T$%;32EIWYVY`SSCTJL:1
MU;<=3P8$U;5M83**U*CB0HO)0DD;@,<\X]N#5OK#,ELP8;LM]6UIE!4H^O'H
M/K4'HC5"]661V>[&$5UN2XRIG)RC:>`<^N#S5BJM:OU:-,NVQC8TDW%\M?$R
M"0RP!Y*L??@<?>INWKF+B[IOP_<W'"HZB4*3Z'GQQZ<_>MJJ6-:3W-47FS);
MMD=%L2@A^3(4D.%8^4>.#[^:N+1<+2"ZE*7"D;PDY`/K@U[I5-FZ/7J2Q72%
M=8Z8LEZ:Y)BOH<"RVK@(5D>.``14UI2VS+1IF'"N#G=F(252'-V[<M2BI1SZ
M\FIBJ$O3]X_KY=[Y(LD:?$E1DQF&G)"<A(QDD$'&<']ZN\3N_!L]]E#+NP;V
MD*W)0<>`<#(%9JI4SIZS<-87:Z25@PKA#2V6`>"]M*=Y'T3X/NHU)Z&TV]IC
M3;$&6_WYF/XSFXD<<)2,^@&`*L50>I(LFY1'[:JRLW&&^R1\[X04KY\@C@>#
MD<CVIHRQ2--:4A6F5*^)>CI(4L9P,DG`SZ#.*G*4K__1NNO=,7#5"[0PPU'=
MAQ)8D24/.E!<`XVC`/H36QHFP773#$NT27&'[:V\I<%Q*SW$H4<[%`CTSYS[
MU:*I]WL-WE=0(5_:B1)$.%%4REIQXI6I2LY5^4@><59K:E]$!M$B,Q%6G([,
M=6Y"!G@`X'ICTK:/CBJ1IRR:DL,Z^S%0H+[UVF&0C_&B`V.<`_)DXSZ5=AG'
M/FH[44>;,T[/B6]*%2I#"VF]Z]J05#&2?IG-0NC[/<;';;7;I%HAH,1@MO3$
MOA2CGD[1MSR<>35LJ&O5OEW6="B*:_Y,2OO2%I?*%E2>4``<X"L$\^@J(T7I
MRYZ<O%\2\VW^'3I1D1SWRM:2?(5D>O'.?2KA5>U3#E7:%*M:[&S<8C['R*4^
ME!2YSY!\8X((R?/%9](661I[2L"U2Y/Q#T9O:MP$D>2<#/H,X'VJ:JAVG3UZ
M@7G4%QEV:#-5=)*76$KD#Y$ISM"LI^QX]JO:=VT;L;L<X\9K[2E*4I2E*4I2
ME*4I2E?_TNRTI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2O__3[+2E*4I2E*__
!V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cryolife4q2.jpg
<TEXT>
begin 644 cryolife4q2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#__@`<4V]F='=A<F4Z($UI8W)O<V]F="!/
M9F9I8V7_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-#AT5%A$8(Q\E)"(?(B$F
M*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_P``+"`!'`<`!`1$`_\0`
M&P`!``(#`0$```````````````,$`0(%!@?_Q``X$``!`P,#`@4#!``%`P4`
M```!`@,$``41$B$Q$T$&(E%A<10R@14C,Y$D0E)BH0<6@E-RL<'P_]T`!``H
M_]H`"`$!```_`/LM*4I2E*4I2E*4I2E*4I2L9'&:S2E*4I2E*4I2L$@8R>>*
M_]#[+2E*4I2E*4I2E*4I2E*4KA>+FWC:6WV9<A@L26%%+*]/4RZ@84>2,$[=
M^]49]XF-^)G92F%*M5L*([FE[2HO.Z?.48\P`4D#?NHC-;1V';;XC4N6`Z+B
M^\(\A,QQ73\I5I4V?*``D[CC'O6WA9EVUR3:IK>J7]*AXR42W'DO#."2%_:<
M[[;'/M7'EN35^+I#;:)#74N;33<\S5!MH!IM9;+7!U#4!D8)57;1XAFN+1(7
M%83;Y$M<-O#AZP4%*3J(QC&4G;D#>N99/$4^U>&+6_<(\=V,Y"4ILQWBIS]M
MLK\V=CD)/'!P*ML^*KLY!6Z;2GJK+'0*^HTVHNKTZ25)SE.<Y`P161=_$S$V
M[H<BQ)?TC+):9CZLZE9R=QN,9..=L#FNHU<5SO##\OJ-]4,NA19U)"5)R",*
M`4""-P=P:\G:;A(\.D2),5;*%6GKHC"<J0'UI*<K45?QGS#V.3Z5Z']>N$.4
M85Q9B*?S'4%QUJT:7'.G@YWR.1Z^U5;A?!^J)DJ:U(MDB2@I0K)<"8X7_>Y'
MXK,3Q3<S"<F3;:E$=M#3ZG0E2$I;4K"ONW)2/-D;$9XK2X^,9+%N,V(RRZ`A
MZ0AL(6LN1T'`7D8"0K<Y/J-C4ZO$EQ49KK<:*&&I+41@K6K)6L(.I9X"1KX&
MYQVK_]'Z)8'92K_?$SEQU.H6PG+!.G&C(R#N#OQ\5%XH8FR;S9V[?,7&D(#[
MK8"L(<4E*<)6.Z3D@^F<UR57L29<R]AUQANUOQE2F%*.6!I6AY*AQL%9]](-
M1QI,S4F"])?+GB5UN6RDK.6D:LNI3Z`-!'Y4:^@5Y;QC=?%=ME6M'ARTMSFG
MGL2E*&=`R,#D8!R=_:O4UYKQB_=&#:E6A"7)1DK"4*5@*'1<S[$CD`[$@523
M>DVZ+;XMA2Y,5.#SSLB0E3B]:-.H+3E)"LJP1MIQQ4S_`(CO*6'I?TD2.U#A
MLR9#+JBI9*]6I`(.!@)V.]647RYBYDN-Q!!_4#"2E(5U3Y<A><XYVQCCO5"!
MXJOMPC+DL6ILH=CN.L!S#82H*`"2HJ\V<G.R<$8[UO-\6RV+.'HZFGYK*'G'
MV1%4G`;."""L:,$@$Y/.V:2O&SL:2&U1&]+91)DDJ/[,-24_N^Y"E$8]$*KT
M=IF.3[:Q)?0EMQY`<Z:3]J3NG_C'YS7EUL1)D2[39T6-.N<:0Z%,R7RWT6TG
MR!)P=`*,*!`W)YJ1SQ9<7)"$6^V%;:(T=]:%#)6'>VLJ`3@=R#DU;1X@GJDI
MD%,7Z1=P,(1AGKCS%&LG..1JTX^W?-11;]>9,:VEPV^,Y<NHXE:DJ4AM"0,)
MY&I9SGD``'G%11?$ZG(_U\H1$NIC2/WV=;B#H?#:<#.X)P?_`+KJ^&[O*NB)
MS<QH(?A2>BHA.G5Y4J!*=2L'S8QD\5YV\ENW3Y+UKZ;;<J!)*'8CQ6XZL%*E
MJ6.VD!6DY.Y(VV%=6%`@?JTNV6UQ34%V"VIP1G2`E14H!04#LI21N>2`#7/D
M2'$>`[="2B<6)$10??C(4XM"$IXR,D%6PSZ9JG=;LY(M%E4MFZ-QF$0WPMJ.
MX>LX7$C"L#@`'8\E0]*^A`Y`.^_K6:4I2E*4I2E*5__2^Q.LMOMEMYM+B"02
ME0R-CD?\BJKUGMTB>B<]":7)1@I<*=\C@^Y';TK#5DMC$QR8U`82^[JUK"-S
MJ^[^^_K6UOL]NM06($-J/U,:M`YQP/@=AP*D<@1'DN)<C-+#KB7%@I'F6G&%
M'W&D;^PJ)-FMJ;@;@F$R)1)/4T[Y(P3\D;9YJ.'X?M%O=+L2W1V5%)1Y$8`2
M>0!P`>^.:VBV.UPD*1&@LMI4I*B`GNDY3_1X]*S*LUMFON/R8;;CCC8:6HC=
M20<@'X.X]*FCP(D2&(<>.VW'`(Z:1L<\_.<FJ\*PVBVH<1#ML9A+J="PAL>9
M/H?;VHS8;3'B/1&K>PEA_'51HR%XXS\=O2I8UJM\-"41H3#24J*@$-@>8C!/
MR1L3WK6+9[;";>;BP&&4/C#J4-@!8]#[;G;WI(LULEH9;D6^.ZAA.EI*F@0A
M.,8`]/:IEPHKC+K"XS2FGOY$%`PO8#<=]@/ZJLBPVQH-)8AML):>#P2TG2%+
M`(!5CG&>_M5U33:G$.*;25HSI41NG/.#4:H,18?"HK)$D8?!;'[NV/-Z[;;U
ML8S!<:<++96R"&U:1E`.Q`].*EI2M5-H6I*E(2I2#E)(R4G&,CTV)JM(M%ME
MMK1(@1G4K7U%!;22%+QC4=N<;9J;Z6/H4CZ=K2I(0I.@8*1P#["L]!G_`-%O
M[]?VC[O7Y]ZK"SVL+?6+=%U21AX]%/[@_P!VV]8-EM18:8-MBEIG);064X1G
MG`QWJP8D9143':.IOI*R@;H_TGVW.WO6K,*/'E/R6T8=?"0LY[)&$@>@&3_=
M1R[1;)[R7IEOC2'$?:MUE*B/R16[]M@27FGY$*.ZZS_&M;8)1\$\4%O@B=]8
M(C`ED?S=,:\<<\^U5[G:C.BMQV'&&6VU9Z;D9+K:AC;RGC'.U9M]FB0+:B$6
MT/)"5!:G&T^?4=2M@,`$GCBK$)B$Q'`@-,-LDY'02`DGCM6&;=!C/N/L0X[3
MSW\CB&DI4OY(YK:+"BP4%N)&9CH4=12T@)!/KM4J6T(;Z:4)2@#&D#`Q\5__
MT_L?31H"-"=(QA.-ACBL@@D@$9'(]*PAQMPJ"%I44'2K2<X/H:VI2E*4I7DY
MH1(\./S7R^[+?E.(C-ID+;PX5EM"?*1L,#/P36UWM#:6+1;$29:YSA;9^H$I
MQ*@VWA3BS@X)(&,GNH5$XM9=<N9DO?6)O`B!'5(3TBL(T:>-T'5QG)SFNM`N
M"XOAIZ4^'9*H1>1L"I;H;6I(^20D5Q_"TE=V3?82KQ*<?,A*U.H"DED*;02E
MO4GR@'4!MGO[U5<<D'PE9;G,1*N$)F!E]MJ26W%ND)T*)U#4>1C.<J!WKT5N
M4Z;+'MUV=>$PQ$_4.IU)P2,']P;:O<'/>N7;(Z7?U>U26WVNB^A;,/ZU1!24
M>7#F<X44J)3VJFQ'G3[+$<*BZ;<Y*3*B.3G&E`A6R`XG[](V!.QV-69JUB4Q
MXB+:G[:6(VEGZQQMQC*CYM`\JON3D$Y.*O>+NNLVEAEIUX/3=*V6I)8Z@#3A
MP5#MD`X[XKE,B_VFXL(`9><1!D/*1(D+6&V^JDH;UXRH@;:CZ=ZZ#OBJ6N/(
MG0X3)APH[<B0'G2EQ06@+P@`8R$GD\G;WJ2/XBGO3@I<)E$%4Y<)*@Z2Z2`<
M+QC&,C&.:U\.^)YE\D-*5;7&XDAM3C3NA8",$8"BH`$D'_+Z5Z6O*JOGB4?]
M0Q9TV0&R='49V#SISG5Q]WET\]Z]57$D(8E72Y?J#A$2-&;!1U%)"02I2E'!
M_P!HW_VFN,W!BQ_!CLR7&>>,ITR(L5;[F0IS"6F_NSQIR/4FCUJ8CI7;YTQX
MIM=G0XRX7E`I<RO6[G.Y&E//'YKL>'WY#DA]+ZB2Y&CR%`Y\KBTD*'M]@./<
MUQH]Y3)\<H,A^;'ZL>2PB.MIQ"&TH4C"\D:<GS'5G8:1\Z,/K@V^;<K`E28S
MZ&HL(R'2I,AY2](?5G.$Y4-^58SZ5VK'<3&C&V2([QD0G4QG%-%3X45)"@LJ
MQD`ZM\@8KSDIYZ'9F+M%?=%UE+E)?4%DDA*'21ISCR%*<>F/>NJQ"MS%S7;6
MWBJ!)@-N.H4^H!;A7A"M6>5[@^N.]4RRXYX(O\5QY^&["<?);C2#AK"-:4)7
MR4X()&VY(XKT%\6H>#9[@40K]/<.H'!SH/>O_]3V\!"[!:5/IMD6WR))::9Z
M+BY/64>VG"=^>_YJ)?C:8U;(4A4-DO2778ZTE1`84AS1U5X)PV/\V^Q(&:]D
M,Z1D@G'(KSGCBX^)+;96WO#%O1-EEY*5I4G5I1@[@9&=\#\UWH:WW(3"Y3:6
MI"FTEUM)R$JQN`?8US_$=V>LUM0_'CE]YU]MA`QD)*CC)&1GXR,[5I:;Q,D1
MVA<+<^V\MY36IMKRX&,*(R=`.>">QKE,WWQ)(CQWTM6QM$F&[*3D+44!!3Y3
MOOD*&^V-^:D=\6O=6"ZPVA<=XQDOHZ9RT7L8\^0,X4#@`_BHK9-4_=6WF`S'
M6(,D)#BE*0"F3IR23GMFNY>GPP(!+27-<UI`U*(TDYW&.3[5YZ5>[S+L+A=^
MB;-PMLAYDMH6>EH`V)SOD*YVP1WJ87:?;H3C$86YEJUP6GG$K04];*22$`'R
M#;&=]S[5R;Q*>ES)ZWQ)0^VV%L)$7K8!/E!!!"4A.%$C!)4=_+BNU;+E/*8M
MOC260E,8R`_-RM3C9<*4#8C<)`U'MD5.;]/CL2;C+3%3;X\Y3"].K4AI*R@N
M*.<;'!(QL,U&/$%SDIU-?0Q`F)]9_B=7G;*E:!R,>5(*CO@J&U5F;@9%T3+2
MPD*EO1"$N$Y9*F%D';&2.,?-4+;>[I;;5;X4=AEZ0^U(E./)9\JBES&""L;[
M[JR<>E>GGWA]BTQWD(9:E/J90M+J]2(Y<(W5@[@;@>IQO521=;FW*3!3.MJ'
M&HRI#DEU!"'<*(TA.K;&/,<G&1M517B.]2V%RH3,-EMMJ*OHOI45*+V,@D$8
M`R"-CGVKN6B7*?5-CS5-+>B2.EU&DE(6"A*@<$G!\V.>U=*E*54:MD5I95HU
M_OJD("]PVLC!*?3DG_R-3EADR!(+:2\E!0%XW"202,^F0/ZJNJT6]5P_4#%;
M^KQL]C<;8SZ9QMGG%2PH;4"&U%9U:&Q@%1R2>22?4G)J1#3;:W%H0E*G#J60
M-U'`&3^`!^*C,**66F#';Z3*DJ;1I&$E/!`]JW?8:E,+8?;2ZTXDI6A8R%`]
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M9!N"VES(C+ZF3ELN(!TUNQ$:CO2'D:BN0L+65'/```'H,#_YK=UAE[/5:0YE
M"D'4D'RG&1\'`R/:J,?P[98C;K<>UQ&D/)T.)0T`%)]"/2K<.#%M['0AQVV&
M\YTH3@$^I]36C=K@,S79K<-E$EX8<="!J4/<U&U9+4S&>C-6Z,AE\ZG6PT-*
MS[C_`/8J5BWPHT0Q&(K+<=6=324`)5GG([YJ93;:VRTM"5(4-)01D$>F*CD1
MXDIOZ62TTZA0STE@$''?'M6K=N@LH*&H;"$*04%*6P`4DDD8],D[>]6$I"$A
M*0`D#``["LTJ-^.S*86Q(:0ZTL84A:00?D&L1HL>$PEB*PVPTGA#:0D#\"LI
MCLH2E*66TA*2E("0``>0/;:H56R`I]#ZH4<NM@!"RT,I`XP>V.U2&'%4DI5&
M9*2DI(+8P03DCX)WJ1;:'-.M"5:2%)U#.".#\UI]-'T!'0;TI24!.@8"3R/@
M^E1OVV#*<:<D0F'EL_QJ6V%%'QGBLR($.8I*I,5EXIX+B`<5B3;H,P-"3#8>
M#)RWU&PK1\9XJ*Y6T3X*X25I89>5^^`V#U$'[D^Q/KO4LFW09O3^JAL/](Y;
MZC85H^,\5,66BO66D:L@ZM(SD<&H7[=!E-(:D0V'FT'*4.-A02?4`U(N+&<2
MM*X[2DN)"5A2`0H#@'U%0JM-M6PVPNWQ5--$EMLLI*4$\X&-JL%EHYRV@ZL9
M\HWQQ_5;!*4E12D`J.20.36:_];[+2E*4I2E*4I2E*4I2N'XN6^BR(5%"2\)
MD;0%**03UD;$CM5-V]7I<N+&:$)MUNY?2RLE12M/2+@T]QL1^1Z5&B^7YD%M
M;<!]V1=5PV"5J0EM`2HY5MN?+L.^:ZMNNDJ2'4R4QFE0WU,R5)62D@("@4?V
M,@\8-4&%/SFHB-:TN7209C@R04,)P4I]L@-@_*JI_P#?JNJ4&"GRI,=1ZG$[
M.`QQZ;YJ:9XX%OFN,28B0W#6M,]P.?P9_A.._4_XS6KWC5Z%(1&FP6T/-J0Y
M,PYM'C*2G]TY&^%JT_\`BH]JZ+E^DFQPI;<=I,F>XAMI#BSH1K)TE1Y^WMW.
MU%W"^">F`VS`6\B*7W5ZEA*CJ*4I2.V<;DG;WJHCQ:[/;;-NCM?O.M1DK>4=
M+;RDJ6M*L?Z0`,=U'&U4YUU?D2V?JVFR]!7,:<#*U!MTAC5L>1LK!]"#O5<W
M>9;IMPNICQWE*9A,QFTI4I;74VP3G<9).W.!7I;-=9<N"\Y<8ACNM.J0D8T]
M8``Y"221W&">U4$WZZ&SQ[@4P")Y:3&0%*PSU#@=16=\>V-]JQ^OW95P1:FV
MH2I8DJ9<?\W2P&@X"$YSG?!&??-3V:\W25*AMW%B*V)L9QY"6%*)04*2""3L
M<Z\[8Q[UZ"E*_]?[+2E*4I2E*4I2E*4I2E*4I2E*4I2E*4K1UEI]`0\VEQ(4
M%`*&1D'(/X(!JO(M4"6E27XC3@6Z'E93RL``*^0`!FJ5P\+VRX26WG([0Q($
MAY.C(>4$*0,^XU9S[5;19K8W#1$1!92P@*"4!&PU`A7]@G/S7__0^PICLI?Z
MR6DAS0&]0&^D'./BH_H(>_\`A6=W>N?VQ_)_K_\`=[\T<M\)TO%R(RLR-/5U
M-@]33]N?7':LNPHKZG%/1FG%.M])PJ0"5HW\I]1N=O>M7K;!D-.M/1&7$.I2
MEQ*D#"@G[<_';TK#-OC0V=$%AEA24%""$;#<G?U&3GFJT.Q1&+2JWR6VY2'5
MJ=?*VP`XXI14I6.VYV]-JLM6R`PPVPU#80TV%!"`@82#S_??UK9<"&XTXTN*
MRIMU(0XDH!"DC@'U`K6-;8,-IMJ-#9:0THJ;"$`:5'DCW.3O4:++:FP^$6Z,
MD21AX!H8<[[_`)WJ6+;8,)IMN+$990T2I`0@#23R1[FI4L,H4A26D`M@I00D
M>4'&0/Z']5)2E*4I2E*4I2E*4I2E*4I2E?_1^RTI2E*4I2E*4I2E*4I2E*4I
M2E*4I2E*4I2O_]+[+2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*__T_LM*4I2
..E*4I2E*4I2E*4I2O_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
